In relation to the question could Janssen be referring to another 'academic/biotech consortium' - other than Phylogica - utilising endosomal escape peptides for intracellular delivery of Centyrins, the comment by Paul Watt dated 27 June 2013 is instructive;
"We are not aware of any other peptide discovery company that has overcome the challenge of identifying cell-penetrating peptides."
In relation to the question could Janssen be referring to...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4000 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 40248 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |